The Drug Enforcement Administration (DEA) has proposed a rule to place alfaxalone, an anesthetic used primarily in the veterinary field under the trade name Alfaxan, as a Schedule …

Alfaxalone is a Class IV controlled substance.

Nov 17, 2025 · Alfaxalone was designated a Schedule IV controlled substance due to its abuse potential and dependence risk, stemming from its CNS depressant effects and …

This substance record has relationships which can be visualized as a network with other substance records. A simplified representation of that network can be interactively explored …

Feb 27, 2014 · The DEA estimates all anticipated alfaxalone handlers to be DEA registrants, and currently 98% of DEA registrants (most of which are small entities) are authorized to handle …

Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration

Feb 27, 2014 · SCHEDULES OF CONTROLLED SUBSTANCES: PLACEMENT OF ALFAXALONE INTO SCHEDULE IV; DEA-370

Currently, a human form of alfaxalone is in development under the name "Phaxan": alfaxalone will be dissolved in 7-sulfo-butyl-ether-β-cyclodextrin, which, unlike the cyclodextrin used in …

Mar 25, 2013 · Pursuant to 21 U.S.C. 811 (b), this document contained an eight-factor analysis of the abuse potential of alfaxalone, along with HHS' recommendation to control alfaxalone under …

Thus, abuse of alfaxalone may lead to limited physical dependence relative to the drugs or other substances in Schedule Ill. FDA therefore recommends that alfaxalone be controlled in …